Term
Complement proteins are synthesized where? |
|
Definition
|
|
Term
What is common b/w the alternative and classical complement pathways? |
|
Definition
Both pathways generate the "C3b" fragment |
|
|
Term
What complement pathway leads to osmotic lysis of cells or microbes? |
|
Definition
Terminal pathway of complement cascade ; this is done by MAC complex |
|
|
Term
Complement component C3b can bind to what in circulation ? |
|
Definition
|
|
Term
How many base complement proteins are there? |
|
Definition
|
|
Term
When is classical complement pathway initiated ? |
|
Definition
Only when IgM or IgG Abs bind to antigen or when antigen/antibody complex (immune complex is formed) |
|
|
Term
In an immune complex what is bound to Ab and what is bound to complement ? |
|
Definition
Antigen is bound via Fab region of Ab Fc region binds to complement protein |
|
|
Term
C1 is composed of what 3 components? |
|
Definition
|
|
Term
Why is IgM more efficient at complement activation than IgG ? |
|
Definition
|
|
Term
What is the classical complement pathway C3 convertase ? |
|
Definition
|
|
Term
What does the C3 convertas complex in classical complement pathway do ? |
|
Definition
It cleaves C3 to C3a and C3b |
|
|
Term
What is hallmark of classical complement pathway activation ? |
|
Definition
Formation of C3 convertase |
|
|
Term
What is required for C5 convertase formation in classical complement pathway ? |
|
Definition
|
|
Term
What is the C5 convertase and what does it do? |
|
Definition
C4b2a3b ; it cleaves C5 into C5a and C5b |
|
|
Term
|
Definition
Are anaphylatoxins Bind to mast cells and basophils, induce degranulation, and release of histamine and other inflammatory mediators |
|
|
Term
Function of histamine is ? |
|
Definition
Increases vascular permeability |
|
|
Term
C5a is chemotactic for what? |
|
Definition
|
|
Term
When is anaphyhlatoxin C4a generated ? |
|
Definition
Only following activation of the classical complement pathway |
|
|
Term
What are the many function of C3b ? |
|
Definition
It serves as an opsonin on microbial surfaces Facilitates elimination of immune complexes Amplifies complement activity is required for formation of C5 convertases in both alternative and complement pathways |
|
|
Term
MAC is formed by what complement proteins ? |
|
Definition
|
|
Term
|
Definition
Is a weak kinin that increases vascular permeability , and so contributes to genesis of inflammation |
|
|
Term
What is the C3 convertase in alternative pathway ? |
|
Definition
|
|
Term
What is the C5 convertase in terminal pathway ? |
|
Definition
|
|
Term
Components of the Terminal / Common Complement pathway ? |
|
Definition
|
|
Term
What is the initiator molecule for generation of MAC in the terminal complement pathway ? |
|
Definition
|
|
Term
What are the complement proteins in the alternative complement pathway ? |
|
Definition
C3b, Factor B, Factor D, Properdin, C3, C5 |
|
|
Term
How is alternative pathway activated ? |
|
Definition
Invasion of an infectious agent causes spontaneous creation of C3b (or "tickover") |
|
|
Term
What happens to spontaneously generated C3b in absence of microbial infection ? |
|
Definition
C3b is rapidly inactivated either by interaction with water or complement regulatory proteins |
|
|
Term
|
Definition
Causes hydrolysis of Factor B to Ba and Bb |
|
|
Term
What is the alternative pathway C3 convertase ? |
|
Definition
|
|
Term
What stabilizes the C3 convertase in the alternative complement pathway ? |
|
Definition
|
|
Term
What is the alternative pathway C5 convertase ? |
|
Definition
|
|
Term
C1 INH (C1 esterase inhibitor) does what ? |
|
Definition
Inhibits C1 and the protease kallikrein |
|
|
Term
Kallikrein links what two things ? |
|
Definition
The complement and intrinsic coagulation pathways |
|
|
Term
What does DAF (Decay Accelerating Factor) do ? |
|
Definition
Blocks formation of alternative and classical pathway C3 convertases, by binding to C4b and C3b |
|
|
Term
What does C4bp (C4 binding protein) do ? |
|
Definition
Is a cofactor for Factor I Binds to C4b preventing its attachment to cells |
|
|
Term
|
Definition
Factor I cleaves C4b to its inactive form C4bi |
|
|
Term
What does AI (Anaphylatosin inhibitor) do ? |
|
Definition
Binds to C3a, C4a, and C5a and inhibits their binding to receptors on mast cells and basophils |
|
|
Term
What are the classical complement pathway regulators ? |
|
Definition
C ACFD C1 INH AI C4bp Factor I DAF |
|
|
Term
What are the alternative complement pathway regulatory proteins ? |
|
Definition
FFAD Factor H Factor I AI DAF |
|
|
Term
|
Definition
Inactivates C3b/C4b via CR1 |
|
|
Term
What does Factor H do in alternative pathway? |
|
Definition
Competitively binds with C3b, inducing dissociation of this convertase |
|
|
Term
What are the 3 MAC inhibitors ? |
|
Definition
HRF (homologous restriction factor) S-protein / vitronectin CD59 / HRF20 |
|
|
Term
What does kallikrein do ? |
|
Definition
In presence of cofactor kininogen, Factor 12 is converted to Factor 12a |
|
|
Term
Do Factor 12a and kallikrein reciprocally activated each other ? |
|
Definition
|
|
Term
Proteolytic hydrolysis of kininogen does what ? |
|
Definition
Generates kininogen(a) and bradykinin (a vasodilator that increases vascular permeability). |
|
|
Term
What is the complement ligand fragment for CR1 receptor ? |
|
Definition
|
|
Term
CR1 is found on what cells ? |
|
Definition
Phagocytes and Erythrocytes |
|
|
Term
CR1 binds with C3b or C4b to do what ? |
|
Definition
Opsonin mediated recognition of antigen Clearance of circulating immune complexes |
|
|
Term
CR2 receptor binds with what complement ligand fragment ? |
|
Definition
|
|
Term
CR2 receptor is found on what cell type ? |
|
Definition
|
|
Term
CR2 binding with C3bi occurs in what mode of infection ? |
|
Definition
Mode of Epstein Barr virus infection |
|
|
Term
CH50 complement test is for what ? |
|
Definition
Classical complement pathway |
|
|
Term
If CH50 test is not available, then what is done ? |
|
Definition
|
|
Term
Does CH50 test detect deficiencies in specific complement components ? |
|
Definition
No, it measures total classic complement pathway activity |
|
|